he purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long-term efficacy or effectiveness for antiepileptic drugs (AEDs) as initial monotherapy for patients with newly diagnosed or untreated epilepsy. All applicable articles from July 2005 until March 2012 were identified, evaluated, and combined with the previous ysis (Glauser et al., 2006) to provide a comprehensive update.
The prior ysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were yzed using a noninferiority approach, (2) the definition of an adequate comparator was clarified and now includes an absolute minimum point estimate for efficacy/effectiveness, and (3) the relationship table between clinical trial ratings, level of evidence, and conclusions no longer includes a recommendation column to reinforce that this review of efficacy/evidence for specific seizure types does not imply treatment recommendations.
This evidence review contains one clarification: The commission has determined that class I superiority studies can be designed to detect up to a 20% absolute (rather than relative) difference in the point estimate of efficacy/effectiveness between study treatment and comparator using an intent-to-treat ysis. Since July, 2005, three class I randomized controlled trials (RCT) and 11 class III RCTs he been published. The combined ysis (1940-2012) now includes a total of 64 RCTs (7 with class I evidence, 2 with class II evidence) and 11 meta-yses.
New efficacy/effectiveness findings include the following: levetiracetam and zonisamide he level A evidence in s with partial onset seizures and both ethosuximide and valproic acid he level A evidence in children with childhood absence epilepsy.
There are no major changes in the level of evidence for any other subgroup. Levetiracetam and zonisamide join carbamazepine and phenytoin with level A efficacy/effectiveness evidence as initial monotherapy for s with partial onset seizures. Although ethosuximide and valproic acid now he level A efficacy/effectiveness evidence as initial monotherapy for children with absence seizures, there continues to be an alarming lack of well designed, properly conducted epilepsy RCTs for patients with generalized seizures/epilepsies and in children in general.
These findings reinforce the need for multicenter, multinational efforts to design, conduct, and yze future clinically relevant adequately designed RCTs. When selecting a patient's AED, all relevant variables and not just efficacy and effectiveness should be considered.
查询信源地址
- 2022-05-04青少年癫痫病的疾病是什么
- 2022-04-21癫痫风湿热死亡简析
- 2022-04-202013年国际抗癫痫分会抗癫痫药使用指南
- 2021-11-03重复性发作癫痫病预防的方法
- 注意┃要好好照顾,不仅可以避免妇科疾病,还有助于怀孕!
- 甲硝唑 VS 替硝唑,只是一字之差吗?
- 十个女人,八个贫血,五种常见的便宜货,让你充满气血
- Sci Rep:盆腔淋巴结清扫术对患者的益处分析
- 仙鹤草的功效是什么?
- 宫颈囊肿怎么了 宫颈囊肿怎么护理?
- 男性淋病症状 男性淋病怎么治疗?
- 左上腹痛 男人小肚子左侧疼怎么回事?
- 过年容易得什么病?
- 他们在对抗子宫腺肌病的路上走了太多弯路!
- 布加氏综合征 布加氏综合征如何治疗?
- 美国神经病学会发布了原发性震颤治疗指南
- Eur Respir J:评估慢性支气管炎和危险因素
- 除了痔疮,这个问题也会让你坐立不安
- Br J Cancer:绝经前后激素水平与浸润性乳腺癌的风险有关
- Lancet Psy:Asperger 综合征患者自杀率高
- 附睾炎有哪些表现?
- 第一次同房失败,怎么治疗?
- 争吵和压力会影响夫妻的生活!瑜伽或冥想可以缓解美国健康
- 每四个女人就有一个子宫肌瘤。这个肿瘤有多可怕?
- 这件事对女性子宫危害很大,但很多女性不了解,认为很简单
- 必须走出移动医疗「只圈地 轻盈利」怪圈
- 每个女人都是江湖……
- 治疗宫颈糜烂的偏方 女性宫颈糜烂怎么办?
- 调查展开!没生却被推上手术台?安康老品牌男科摊
- J Allergy Clin Immunol:奥马珠单抗治疗鼻息肉病的安全性:2次随机3次试验
- 2019年10月19日Lancet研究精选
- 异地探视体验升级!我国将进一步扩大门诊费用跨省直接结算试点范围
- 睡眠不好怎么办 睡眠不好竟然会有可能(2)
- 癫痫病食疗方法 现代医学特色
- 癫痫病的治疗方法有有哪几种
- 癫痫病人中枢神经系统为什么会放电 尽早用药可以控制症状
- 夜里抽搐是不是癫痫病?
- 新版医保药品远超2800种 “逢进必谈”的药都有哪些?一起来看!
- 《中国慢性疾病防治基层医生诊疗手册:神经病学分册》完稿出版
- 异性恋体检 定期体检摆脱妇科亚健康
- 不要让你的癫痫治疗法前功尽弃
- 学龄前得了癫痫病有什么症状
- 癫痫病发作是什么征状
- 癫痫病发病的期中是多少?